These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 23594162)

  • 21. Defibrillation testing can reveal 'concealed' lead fracture.
    Bun SS; Duytschaever M; Tavernier R
    Europace; 2013 Jan; 15(1):54. PubMed ID: 22719061
    [No Abstract]   [Full Text] [Related]  

  • 22. Atrial tracking with a single ICD lead in the ventricle.
    Spears D; Selvaraj R; Dhopeswarkar R; Nanthakumar K
    J Cardiovasc Electrophysiol; 2008 Apr; 19(4):440-1. PubMed ID: 18298516
    [No Abstract]   [Full Text] [Related]  

  • 23. Sudden change in R-wave amplitude. Is it a device malfunction?
    Alcalde O; Villuendas R; Pereferrer D; Bayes A
    Pacing Clin Electrophysiol; 2013 Feb; 36(2):249-52. PubMed ID: 22845674
    [No Abstract]   [Full Text] [Related]  

  • 24. Single channel ICD noise without loss of conductor circuit integrity.
    Deyell MW; Patel RK; Cooper JM
    Pacing Clin Electrophysiol; 2012 May; 35(5):616-21. PubMed ID: 21972947
    [No Abstract]   [Full Text] [Related]  

  • 25. Potential role of home monitoring to reduce inappropriate shocks in implantable cardioverter-defibrillator patients due to lead failure.
    Spencker S; Coban N; Koch L; Schirdewan A; Müller D
    Europace; 2009 Apr; 11(4):483-8. PubMed ID: 19103654
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Performance of Lead Integrity Alert to assist in the clinical diagnosis of implantable cardioverter defibrillator lead failures: analysis of different implantable cardioverter defibrillator leads.
    Ellenbogen KA; Gunderson BD; Stromberg KD; Swerdlow CD
    Circ Arrhythm Electrophysiol; 2013 Dec; 6(6):1169-77. PubMed ID: 24099976
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical efficacy and safety of an implantable cardioverter-defibrillator lead with a floating atrial sensing dipole.
    Safak E; Schmitz D; Konorza T; Wende C; De Ros JO; Schirdewan A;
    Pacing Clin Electrophysiol; 2013 Aug; 36(8):952-62. PubMed ID: 23692262
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An algorithm to predict implantable cardioverter-defibrillator lead failure.
    Gunderson BD; Patel AS; Bounds CA; Shepard RK; Wood MA; Ellenbogen KA
    J Am Coll Cardiol; 2004 Nov; 44(9):1898-902. PubMed ID: 15519026
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Implantable cardioverter-defibrillator lead failure: how weak is the link?
    Brinker JA
    Nat Clin Pract Cardiovasc Med; 2008 Dec; 5(12):758-9. PubMed ID: 18838965
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management strategies when implanted cardioverter defibrillator leads fail: survey findings.
    Xu W; Moore HJ; Karasik PE; Franz MR; Singh SN; Fletcher RD
    Pacing Clin Electrophysiol; 2009 Sep; 32(9):1130-41. PubMed ID: 19719488
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Non-determinable defibrillation threshold and inefficacy of implantable cardioverter/defibrillator shocks due to defective connections of the defibrillator lead terminals in the device header port.
    Maagh P; Trappe HJ; Meissner A
    Europace; 2007 Dec; 9(12):1161-2. PubMed ID: 17913694
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk stratification for implantable cardioverter defibrillator therapy: the role of the wearable cardioverter-defibrillator.
    Klein HU; Goldenberg I; Moss AJ
    Eur Heart J; 2013 Aug; 34(29):2230-42. PubMed ID: 23729691
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interaction between cardioverter defibrillator and enhanced external counterpulsation device.
    Celik O; Aydin A; Yilmazer MS; Sarigul NU; Gurol T; Dagdeviren B
    Pacing Clin Electrophysiol; 2013 Sep; 36(9):1104-6. PubMed ID: 23713720
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Estimation of defibrillation threshold using abdominally implanted cardioverter-defibrillator with an additional defibrillation pole in a dual-coil lead endocardial defibrillation system].
    Pazdyga A; Lubiński A; Lewicka-Nowak E; Królak T; Kempa M; Zienciuk A; Raczak G
    Pol Merkur Lekarski; 2007 Feb; 22(128):86-9. PubMed ID: 17598649
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [From implantable cardioverter-defibrillator to cardiac resynchronization therapy with the use of epicardial left ventricular lead. The evolution of the treatment of post inflammatory heart failure--a case report].
    Gepner K; Sterliński M; Przybylski A; Maciag A; Kołsut P; Szwed H
    Kardiol Pol; 2006 Oct; 64(10):1113-7. PubMed ID: 17089244
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fatal outcome in a pacemaker-dependent patient.
    Undavia M; Fischer A; Mehta D
    Pacing Clin Electrophysiol; 2009 Apr; 32(4):550-3. PubMed ID: 19335869
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Electrical failure of an ICD lead due to a presumed insulation defect only diagnosed by a maximum output shock.
    Goldstein MA; Badri M; Kocovic D; Kowey PR
    Pacing Clin Electrophysiol; 2013 Sep; 36(9):1068-71. PubMed ID: 23731252
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biventricular implantable cardioverter defibrillator right ventricle pace-sense ring electrode failure: lead switch fix.
    Venkataraman G; Moore H; Karasik P; Singh S; Fletcher R
    Pacing Clin Electrophysiol; 2008 Jul; 31(7):899-903. PubMed ID: 18684289
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lead system causing twiddler's syndrome in patients with an implantable cardioverter-defibrillator.
    Bracke F; van Gelder B; Dijkman B; Meijer A
    J Thorac Cardiovasc Surg; 2005 Jan; 129(1):231-2. PubMed ID: 15632856
    [No Abstract]   [Full Text] [Related]  

  • 40. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).
    Day JD; Doshi RN; Belott P; Birgersdotter-Green U; Behboodikhah M; Ott P; Glatter KA; Tobias S; Frumin H; Lee BK; Merillat J; Wiener I; Wang S; Grogin H; Chun S; Patrawalla R; Crandall B; Osborn JS; Weiss JP; Lappe DL; Neuman S
    Circulation; 2007 May; 115(18):2382-9. PubMed ID: 17470697
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.